RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant
Foundation Grants for Science Research
Funding Amount
Up to US $900,000
Deadline
Rolling / Open
Grant Type
foundation
Overview
RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant
Status: ACTIVE
Funder: Breakthrough T1D ( Formally JDRF International)
Amount: Up to US $900,000
Last Updated: September 16, 2025
Summary
The RFA aims to advance genetic risk assessment for type 1 diabetes (T1D), enhancing prediction across diverse ancestral backgrounds and refining genetic risk scores (GRS). This initiative will support real-world screening and the prevention of T1D. Grants of up to $900,000 are available for non-profit and for-profit organizations, including academic institutions and industry partners, over a period of three years. Breakthrough T1D is dedicated to making T1D a condition of the past.Overview
Breakthrough T1D Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D is a tax-exempt nonprofit 501(c)3 organization. We are opening doors that were once closed by T1D diagnosis. We lead the way to more effective solutions by connecting the brightest minds to advance treatments, influence policy, and improve access to care. By driving innovation forward, Breakthrough T1D will make type 1 diabetes a condition of the past. Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Summary The main goal of this funding opportunity is to enhance genetic risk assessment for type 1 diabetes (T1D), with a focus on improving prediction across ancestral backgrounds and advancing genetic risk scores (GRS) to support future use in real-world screening, and the detection and prevention of T1D.This Request for Applications (RFA) will award grants to non-profit and for-profit entities such as academic institutions and industry partners of up to $900,000.00 each and up to 3 years.Eligibility
We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.Focus Areas & Funding Uses
Fields of Work
science-research
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Foundation
Nemaline Myopathy Research Grants (RFA)
Amount
Up to $100,000 per year for up to three years (up to five grants available)
Deadline
Rolling / Open
Foundation
WAM Research Grant Program
Amount
Varies
Deadline
Rolling / Open
Annual
Foundation
Paul E. Strandjord Young Investigator Grant
Amount
$7,500
Deadline
December 12, 2026
Annual
Foundation
Jonas Environmental Health Education Project
Amount
$435,000
Deadline
Rolling / Open
One-time
Foundation
Michelson Prizes: Next Generation Grants
Amount
$150,000
Deadline
Rolling / Open
Annual
Foundation
BMS Small Grant
British Mycological Society
Amount
Up to £500
Deadline
Rolling / Open
Ready to apply for RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.